Pacira BioSciences (PCRX) Inventory (2010 - 2026)

Pacira BioSciences' Inventory history runs 17 years deep, the most recent figure standing at $150.4 million for Q1 2026.

• In Q1 2026, Inventory rose 12.42% year-over-year to $150.4 million; the TTM figure through Mar 2026 stood at $150.4 million (up 12.42% YoY), while the FY2025 annual figure was $152.9 million, up 22.02% from the prior year.
• Inventory was $150.4 million for Q1 2026 at Pacira BioSciences, down from $152.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $157.7 million in Q3 2025 to a low of $92.1 million in Q2 2023.
• Historically, Inventory has averaged $115.5 million across 5 years, with a median of $103.7 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Inventory surged 60.45% in 2022, then decreased 10.31% in 2023.
• A 5-year view of Inventory shows it stood at $96.1 million in 2022, then rose by 8.63% to $104.4 million in 2023, then increased by 20.06% to $125.3 million in 2024, then gained by 22.02% to $152.9 million in 2025, then slipped by 1.63% to $150.4 million in 2026.
• The last three Inventory figures came in at $150.4 million (Q1 2026), $152.9 million (Q4 2025), and $157.7 million (Q3 2025), per Business Quant data.